Advances and challenges in gene therapies (part 1)


HOME PAGE COMMITTEE MITONICE COMMITTEE MYOLOGY COMMITTEE PROGRAMS TIMETABLE MYOLOGY MITONICE ABSTRACTS REGISTRATION TO REGISTER GROUP SPACE PERSONAL SPACE USEFUL INFORMATION VENUE AND ACCESS ACCOMMODATION CONTACT US OUR SPONSORS MYOLOGY CONGRESS MitoNice CONGRESS ABSTRACT BOOKS ABSTRACT BOOK MITONICE ABSTRACT BOOK MYOLOGY
Advances and challenges in gene therapies (part 1) Tuesday, September 13, 2022 PLENARY • 13-PM-PLENARY • 3:00 PM > 4:00 PM • Advances and challenges in gene therapies (part 1) • Apollon Auditorium 3:00 PM • S6L1 • Challenges of AAV Gene Therapy Development for Duchenne Muscular Dystrophy > F. Francesco MUNTONI (London, Uk) 3:20 PM • S6L2 • The management of safety of gene therapy of neuromuscular diseases, an emblematic example > S. Serge BRAUN (Evry, France) 3:40 PM • S6L3 • The liver as a model tissue to develop innovative solutions to the existing limitations of AAV gene therapy > G. Giuseppe RONZITTI (Evry, France)